story of the week
Improved Safety of ARBs vs ACE Inhibitors as First-Line Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hypertension
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
Hypertension 2021 Jul 26;[EPub Ahead of Print], R Chen, MA Suchard, HM Krumholz, MJ Schuemie, S Shea, J Duke, N Pratt, CG Reich, D Madigan, SC You, PB Ryan, G HripcsakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.